It is well known that meclofenamic acid, R-2-hydroxyglutarate, and MO-I-500 inhibit the activity of FTO and display anti-cancer activity (Huang et al., 2015; Singh et al., 2016; Su et al., 2018). The gene discussed is FTO; the disease is cancer.